DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Holdings Reduced by Principal Financial Group Inc.

Principal Financial Group Inc. trimmed its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 2.6% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,743,116 shares of the medical instruments supplier's stock after selling 47,439 shares during the period. Principal Financial Group Inc. owned about 0.86% of DENTSPLY SIRONA worth $47,159,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. UMB Bank n.a. increased its stake in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier's stock worth $25,000 after purchasing an additional 753 shares in the last quarter. LRI Investments LLC grew its stake in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock worth $31,000 after acquiring an additional 564 shares during the period. Rothschild Investment LLC purchased a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $32,000. Van ECK Associates Corp purchased a new stake in DENTSPLY SIRONA in the 3rd quarter worth approximately $42,000. Finally, Allworth Financial LP grew its stake in DENTSPLY SIRONA by 40.2% in the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier's stock worth $59,000 after acquiring an additional 625 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY traded down $0.21 during trading on Monday, reaching $17.65. 5,276,088 shares of the company's stock traded hands, compared to its average volume of 3,125,136. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.87. DENTSPLY SIRONA Inc. has a 12 month low of $17.21 and a 12 month high of $37.60. The company has a 50 day moving average of $24.52 and a 200-day moving average of $25.74. The stock has a market capitalization of $3.58 billion, a P/E ratio of -8.53, a price-to-earnings-growth ratio of 0.97 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The business had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the prior year, the firm earned $0.49 EPS. The company's revenue for the quarter was up .4% compared to the same quarter last year. On average, equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

Analyst Upgrades and Downgrades

XRAY has been the subject of several recent analyst reports. Barrington Research lowered their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an "outperform" rating for the company in a research note on Friday. Leerink Partners cut shares of DENTSPLY SIRONA from an "outperform" rating to a "market perform" rating in a research note on Thursday. Evercore ISI lowered their price objective on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating for the company in a research note on Tuesday, October 8th. Robert W. Baird reduced their target price on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a "neutral" rating on the stock in a report on Friday. Finally, Stifel Nicolaus reduced their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a report on Thursday, July 18th. Six research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat, DENTSPLY SIRONA currently has a consensus rating of "Hold" and an average target price of $29.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.